Article | October 5, 2022

Industry Trends: CDMO Outsourcing

Source: ISR Reports

A recent Industry Standard Research (ISR) study explored CDMO outsourcing models to discover patterns within the selection of CDMO partners that sponsors choose at various stages of development, as well as to determine why sponsors made those choices. Partnering with small/niche CDMOs during early-stage development is attractive to sponsors, in part, because those providers are perceived to be more accessible, offering more interaction with expertise early in development to aid in troubleshooting and other problem-solving. By the time Phase III trials or commercial manufacturing commence, respondents prefer global CDMOs because of those providers’ perceived aptitude in fulfilling demands for global recruitment, manufacturing scale, and regulatory support, among other factors.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader